1
Clinical Trials associated with Vaccine PvCS N/C(Malaria Vaccine and Drug Development Center)Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivax
This is a randomized, double-blind, controlled, which seeks to compare two groups of volunteers (naive and previously exposed to malaria) who were made 3 immunizations with a synthetic derivative of the CS protein of Plasmodium vivax in order to determine their protective efficacy. Then volunteers will be subject to an infectious challenge to assess the infectivity of gametocytes in the blood early stage of P. vivax in Anopheles albimanus mosquitoes.
100 Clinical Results associated with Vaccine PvCS N/C(Malaria Vaccine and Drug Development Center)
100 Translational Medicine associated with Vaccine PvCS N/C(Malaria Vaccine and Drug Development Center)
100 Patents (Medical) associated with Vaccine PvCS N/C(Malaria Vaccine and Drug Development Center)
100 Deals associated with Vaccine PvCS N/C(Malaria Vaccine and Drug Development Center)